New York, New York - Score of Tylenol lawsuits filed on behalf of individuals who allegedly suffered acetaminophen-induced liver damage due to their use of the over-the-counter medications continue to move forward in the U.S. District Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP reports.
According to an Order issued on December 15, 2014, the Court has designated a case for the litigation’s first bellwether trial. The Order also directs the parties to submit a proposed pretrial schedule regarding expert discovery and other matters to the Court no later than January 6, 2015. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)
“Our Firm is investigating claims on behalf of individuals who allegedly suffered acetaminophen-induced liver damage due to their use of a Tylenol-brand product. We are pleased that the Court is moving closer to its first bellwether trial, as its outcome may provide valuable insight into how juries will rule in similar Tylenol liver damage claims,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.
Tylenol Liver Damage Litigation
Earlier this year, a Consumer Reports investigation revealed that acetaminophen-induced liver damage sends more than 80,000 people to the emergency room every year. Among other things, the report detailed one study which suggested that exceeding just 4,000 milligrams of acetaminophen for just a few days can result in serious liver problems and other complications. Yet the daily limits recommended for many over-the-counter acetaminophen products come very close to this threshold.*
According to court documents, more than 160 Tylenol liver damage claims are currently pending in the litigation underway in Pennsylvania, all of which allege that Johnson & Johnson and McNeil Consumer Healthcare failed to provide consumers with adequate warnings regarding the risks associated with Tylenol-brand medications. Among other things, the lawsuits claim that liver damage related to Tylenol can occur even when the medication is used in accordance with label directions, and can be severe enough to result in hospitalization, liver transplantation, or death.
Individuals who sustained serious liver damage allegedly due to the acetaminophen in Tylenol products may be entitled to join the growing litigation involving these medications. To learn more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.